GO:0006879 intracellular iron ion homeostasis: Regulation, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0006879 intracellular iron ion homeostasis describes the biological process that maintains a steady-state level of iron ions within a cell, balancing iron uptake, storage, utilization, and export.
Systemic iron balance is governed by the hepcidin-ferroportin axis, which controls dietary iron absorption and iron release from macrophages and hepatocytes.
At the cellular level, iron regulatory proteins (IRP1/IRP2) and iron-responsive elements (IREs) post-transcriptionally coordinate ferritin, transferrin receptor 1, and ferroportin expression to buffer labile iron.
Lysosomal acidity is required for efficient iron release from ferritin and transferrin, and loss of lysosomal function disrupts intracellular iron homeostasis and cell proliferation.
Dysregulated iron homeostasis contributes to ferroptosis, a lipid-peroxidation-driven cell death pathway relevant to cancer, neurodegeneration, and ischemia-reperfusion injury.
CRISPR knockout, point-mutation, knock-in, and overexpression cell models enable causal dissection of genes controlling intracellular iron ion homeostasis.

Description

Intracellular iron ion homeostasis (GO:0006879) is the biological process that maintains a steady-state level of iron ions within a cell. Iron is essential for oxygen transport, mitochondrial respiration, DNA synthesis, and many enzymatic reactions, yet free iron can catalyze Fenton chemistry and generate toxic reactive oxygen species. Cells therefore tightly regulate iron uptake, storage, utilization, and export to keep labile iron within a safe range. This process is coordinated with systemic iron balance through the hepcidin-ferroportin axis, which adjusts iron absorption and release according to body needs. At the cellular level, iron regulatory proteins (IRP1 and IRP2) bind iron-responsive elements (IREs) in mRNAs encoding ferritin, transferrin receptor 1 (TFRC), and ferroportin (SLC40A1), thereby tuning protein synthesis to iron availability. Lysosomes also contribute by degrading ferritin and recycling iron, a step that depends on lysosomal acidity. Because iron homeostasis intersects with ferroptosis, cancer metabolism, and neurodegeneration, it is a major focus of biomedical research. Understanding GO:0006879 requires integrating molecular mechanisms, regulatory networks, and experimental models that can test causality.

intracellular iron ion homeostasis At A Glance

GO ID GO:0006879
GO term intracellular iron ion homeostasis
Ontology biological_process
Synonym cellular iron ion homeostasis; iron homeostasis
Definition A homeostatic process involved in the maintenance of a steady state level of iron ions within a cell.
Major function Balances iron uptake, storage, utilization, and export to prevent iron deficiency and iron overload.
Key regulators IRP1/IRP2, IREs, hepcidin, ferroportin, ferritin, TFRC.
Cellular compartments Cytosol, lysosome, mitochondria, and plasma membrane.
Disease relevance Ferroptosis, cancer, neurodegeneration, and liver disease.

What Is GO:0006879?

GO:0006879 intracellular iron ion homeostasis is defined by QuickGO as a homeostatic process involved in the maintenance of a steady state level of iron ions within a cell. In practice, this means cells continuously sense and adjust the concentration of labile iron ions so that essential iron-dependent processes can proceed without causing oxidative damage. The term encompasses iron uptake, intracellular trafficking, storage in ferritin, utilization in iron-sulfur clusters and heme, and export through ferroportin. It is synonymous with cellular iron ion homeostasis and iron homeostasis.

Why Is intracellular iron ion homeostasis Important in Cell Biology?

Intracellular iron ion homeostasis is important because iron is both indispensable and dangerous: it supports essential enzymes but can drive lipid peroxidation and ferroptosis when labile iron accumulates. The hepcidin-ferroportin axis links cellular iron handling to systemic iron balance, and its dysregulation underlies iron-loading and iron-restriction disorders. Lysosomal iron recycling is required for cell proliferation, and disrupting lysosomal acidity impairs intracellular iron homeostasis. Consequently, genes controlling GO:0006879 are candidate therapeutic targets in cancer, neurodegeneration, and metabolic disease.
Maintains labile iron within a safe range to support iron-dependent enzymes while limiting oxidative damage.
Coordinates cellular iron uptake and storage through IRP/IRE post-transcriptional regulation.
Connects to systemic iron balance via the hepcidin-ferroportin axis.
Supports lysosome-dependent ferritin degradation and iron recycling for proliferation.
Protects against ferroptosis, a lipid-peroxidation-driven cell death pathway.
Is relevant to cancer therapy strategies that target intracellular metal ion homeostasis.
Contributes to lens epithelial cell biology and cataract-related oxidative stress.
Is implicated in liver diseases through metal metabolism and cuproptosis-related pathways.
Provides a mechanistic basis for iron-responsive riboswitch and RNA-level regulation studies.
Offers CRISPR-tractable targets for functional validation and drug discovery.

What Happens During intracellular iron ion homeostasis?

Iron uptake and sensing
In simple terms: Cells take in iron and simultaneously monitor how much is available.
Cells acquire iron mainly through transferrin receptor 1 (TFRC)-mediated uptake of transferrin-bound iron, and this uptake is adjusted to cellular needs. Iron regulatory proteins (IRP1 and IRP2) sense labile iron and bind iron-responsive elements (IREs) in target mRNAs, thereby coordinating the expression of uptake, storage, and export proteins. When iron is scarce, IRP binding stabilizes TFRC mRNA and represses ferritin translation, increasing iron availability. This sensing-uptake module is a core component of GO:0006879.
Intracellular storage and utilization
In simple terms: Iron is stored safely in ferritin and used where needed.
Excess iron is sequestered in ferritin, a multimeric protein that stores iron in a non-toxic form, while iron is also used for heme and iron-sulfur cluster biogenesis. Ferritin expression is post-transcriptionally regulated by the IRP/IRE system, allowing rapid adaptation to iron fluctuations. Mitochondria are major consumers of iron for cofactor synthesis, and their demands influence cytosolic iron distribution. This storage-utilization balance is central to maintaining intracellular iron ion homeostasis.
Lysosomal iron recycling
In simple terms: Lysosomes break down ferritin and release iron for reuse.
Lysosomes degrade ferritin and other iron-containing proteins, releasing iron for reuse; this process requires an acidic lysosomal lumen. Maintaining lysosomal acidity is essential for cell proliferation because it supports iron homeostasis and prevents iron starvation. Glycine has been shown to recalibrate iron homeostasis in lens epithelial cells by blocking lysosome-dependent ferritin degradation. Thus, lysosomal function is an integral part of GO:0006879.
Iron export and systemic coupling
In simple terms: Cells export iron through ferroportin, which is controlled by hepcidin.
Ferroportin (SLC40A1) is the only known cellular iron exporter, and its activity is regulated by the hormone hepcidin. Hepcidin binding to ferroportin induces its degradation, reducing iron release from macrophages and enterocytes and lowering plasma iron. This hepcidin-ferroportin axis couples intracellular iron homeostasis to systemic iron balance. Dysregulation of this axis contributes to iron-related pathologies.
Ferroptosis and oxidative stress
In simple terms: When iron homeostasis fails, toxic lipid peroxidation can kill cells.
Labile iron can catalyze lipid peroxidation, and when antioxidant defenses are overwhelmed, ferroptosis occurs. Lipid peroxidation and iron metabolism are two cornerstones in the homeostasis control of ferroptosis, linking GO:0006879 to cell death regulation. Nanoenabled strategies that regulate intracellular metal ion homeostasis are being explored for tumor therapy. Therefore, maintaining iron homeostasis is protective against ferroptotic stress.

Key Genes Involved in GO:0006879 intracellular iron ion homeostasis

The following genes and proteins are central to intracellular iron ion homeostasis (GO:0006879) and are frequently studied using CRISPR-based models.
GeneMajor RoleResearch Relevance
TFRCTransferrin receptor 1 mediates iron uptakeTarget for iron-uptake studies and ferroptosis sensitivity
FTH1Ferritin heavy chain stores iron and has ferroxidase activityKey marker of iron storage and ferroptosis
FTLFerritin light chain stores ironFrequently mutated or dysregulated in iron disorders
SLC40A1Ferroportin exports iron from cellsCentral to hepcidin-ferroportin axis research
HAMPHepcidin regulates ferroportin degradationSystemic iron balance and inflammation studies
ACO1IRP1 senses iron and binds IREsPost-transcriptional regulation studies
IREB2IRP2 regulates iron-responsive mRNAsIron sensing and neurodegeneration models
NCOA4Cargo receptor for ferritinophagyLysosomal iron recycling research
TFTransferrin transports iron in circulationIron delivery and uptake assays
HMOX1Heme oxygenase 1 releases iron from hemeOxidative stress and ferroptosis studies
FXNFrataxin supports iron-sulfur cluster biogenesisMitochondrial iron handling research
ISCUIron-sulfur cluster assemblyMitochondrial iron utilization studies
SLC11A1NRAMP1 transports divalent metalsMetal ion homeostasis and immunity
SLC11A2DMT1 mediates divalent metal uptakeIntestinal and cellular iron uptake models
CPCeruloplasmin oxidizes iron for loadingIron oxidation and transport studies
STEAP3Ferrireductase for transferrin iron releaseEndosomal iron reduction research
PCBP1Iron chaperone delivers iron to ferritinCytosolic iron trafficking studies

How Is intracellular iron ion homeostasis Regulated?

Intracellular iron ion homeostasis is regulated at multiple levels. Post-transcriptionally, IRP1 and IRP2 bind IREs in mRNAs such as TFRC, FTH1, FTL, and SLC40A1 to coordinate iron uptake, storage, and export. Systemically, hepcidin controls ferroportin stability and thus iron release into plasma. Lysosomal acidity regulates ferritin degradation and iron recycling, and its disruption impairs proliferation. Iron-responsive riboswitches provide an additional RNA-level regulatory mechanism in some systems. Together, these layers maintain GO:0006879 under fluctuating iron conditions.

intracellular iron ion homeostasis and Human Disease

GeneDisease / BiologyPotential Experimental Model
FTH1Ferroptosis and iron storage disordersKnockout and overexpression cell lines
SLC40A1Iron-loading disorders via ferroportin dysfunctionPoint-mutation knock-in models
HAMPSystemic iron imbalance and inflammationOverexpression and knockout models
NCOA4Lysosomal iron recycling and proliferationKnockout cells with ferritinophagy assays
IREB2Neurodegeneration and iron dysregulationKnockout and tagged knock-in models
Ferroptosis and cancer
Dysregulated intracellular iron homeostasis promotes ferroptosis, a form of lipid-peroxidation-driven cell death. Cancer cells often reprogram iron metabolism to support proliferation, and targeting intracellular metal ion homeostasis is being explored as an antitumor strategy. Therefore, genes in GO:0006879 are candidate targets for ferroptosis-inducing therapies.
Neurodegeneration
Iron accumulation and impaired iron homeostasis are associated with neurodegenerative processes, and IRP2 dysfunction has been linked to iron dysregulation in neurons. Maintaining intracellular iron balance is protective against oxidative damage in the nervous system. These mechanisms make GO:0006879 relevant to neurodegeneration research.
Liver disease and metal metabolism
Copper metabolism and cuproptosis intersect with iron homeostasis in liver diseases, and metal imbalance contributes to hepatocyte injury. Hepcidin-ferroportin dysregulation alters systemic iron distribution and can affect liver iron loading. Thus, GO:0006879 is mechanistically linked to liver pathology.
Ocular and lens biology
Glycine recalibrates iron homeostasis in lens epithelial cells by blocking lysosome-dependent ferritin degradation, linking GO:0006879 to lens oxidative stress. Lysosomal iron recycling is required for cell proliferation, and its disruption affects lens cell viability. These findings suggest iron homeostasis is important in ocular disease models.

From intracellular iron ion homeostasis-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of a candidate gene alter labile iron pools?CRISPR knockout cell line
Does a disease-associated variant change iron handling?Point-mutation knock-in
Where does a protein localize during iron stress?Tagged knock-in
Does overexpression of a regulator protect from ferroptosis?Overexpression cell model
Which genes modify iron homeostasis in a genome-wide screen?CRISPR library screening
How does lysosomal acidity affect iron recycling?Knockout plus lysosomal perturbation

How to Study the intracellular iron ion homeostasis Process

MethodWhat It MeasuresTypical Application
CRISPR knockoutGene requirement for iron homeostasisCausal gene discovery
Point-mutation knock-inEffect of disease variantsVariant functional validation
Tagged knock-inProtein localization and interactionsIron trafficking studies
OverexpressionGain-of-function effectsFerroptosis protection assays
RNA-seqTranscriptional responses to iron stressIRP/IRE network analysis
ProteomicsProtein abundance and modificationsIron-dependent protein regulation
Lipid peroxidation assayFerroptosis activationOxidative stress phenotyping
Lysosomal acidity probeLysosomal functionIron recycling studies
CRISPR knockout and phenotypic assays
CRISPR knockout cell lines are used to test whether a candidate gene is required for intracellular iron ion homeostasis. Phenotypic readouts include labile iron measurement, ferritin levels, and ferroptosis sensitivity. These approaches provide causal evidence linking genes to GO:0006879.
Point-mutation and knock-in models
Point-mutation knock-in models can test disease-associated variants in iron homeostasis genes such as SLC40A1. Tagged knock-in models allow localization and interaction studies of proteins involved in iron trafficking. These models refine mechanistic understanding beyond simple loss-of-function.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can reveal how iron stress reshapes gene expression programs linked to GO:0006879. Iron-responsive riboswitches and IRP/IRE networks can be interrogated by combining transcriptomics with iron perturbation. Such datasets help identify downstream effectors of iron homeostasis.
Imaging and biochemical iron assays
Fluorescent iron sensors and biochemical assays measure labile iron and lipid peroxidation in live cells. Lysosomal iron recycling can be assessed with ferritin degradation assays and lysosomal acidity probes. These methods connect molecular mechanisms to cellular phenotypes in GO:0006879 research.

How CRISPR Can Be Used to Study GO:0006879 intracellular iron ion homeostasis

Knockout

CRISPR knockout of genes such as FTH1, SLC40A1, or NCOA4 can reveal their requirement for intracellular iron ion homeostasis. Knockout cells are then challenged with iron loading or deprivation to measure labile iron and viability. This approach provides direct causal evidence for GO:0006879 gene function.

Point Mutation

Point-mutation knock-in can model disease-associated variants in iron homeostasis genes, including ferroportin mutations. These models help distinguish loss-of-function from gain-of-function mechanisms. They are valuable for testing genotype-phenotype relationships in GO:0006879.

Knock-in

Tagged knock-in of iron homeostasis proteins enables localization and interaction studies in native chromatin context. Fluorescent or affinity tags allow tracking of ferritin, ferroportin, or NCOA4 dynamics. Such models bridge molecular mechanism and cellular phenotype in GO:0006879 research.

Overexpression

Overexpression of iron storage or export proteins can test whether increased capacity protects against ferroptosis. Overexpression models are also used to study hepcidin-ferroportin axis components. These gain-of-function systems complement knockout studies of GO:0006879.

How EDITGENE Supports intracellular iron ion homeostasis Research

Researchers studying intracellular iron ion homeostasis-related genes often need to determine whether a candidate gene is causally involved in maintaining labile iron balance, responding to iron stress, or modifying ferroptosis sensitivity. EDITGENE provides CRISPR-based cell model services that enable such causal experiments across knockout, point-mutation, knock-in, overexpression, and library screening workflows.
Contact EDITGENE today to design your custom CRISPR model for intracellular iron ion homeostasis research.

Frequently Asked Questions About intracellular iron ion homeostasis

It is the biological process that maintains a steady-state level of iron ions within a cell, balancing uptake, storage, utilization, and export.
Key genes include TFRC, FTH1, FTL, SLC40A1, HAMP, ACO1, IREB2, and NCOA4.
It is regulated by IRP/IRE post-transcriptional control, hepcidin-ferroportin signaling, and lysosomal iron recycling.
Ferroportin exports iron from cells and is degraded by hepcidin, coupling cellular and systemic iron balance.
Lysosomal acidity is required for ferritin degradation and iron recycling, and its loss impairs cell proliferation.
Labile iron promotes lipid peroxidation, and dysregulated iron homeostasis can trigger ferroptosis.
Ferroptosis-related cancer, neurodegeneration, liver disease, and ocular oxidative stress have been linked to iron dysregulation.
CRISPR knockout, point-mutation, knock-in, and overexpression models can test causal roles of iron homeostasis genes.
Labile iron sensors, lipid peroxidation assays, lysosomal probes, RNA-seq, and proteomics are commonly used.
Cancer cells reprogram iron metabolism, and targeting metal ion homeostasis is an emerging antitumor strategy.

Conclusion

GO:0006879 intracellular iron ion homeostasis is a central biological process that integrates iron uptake, storage, utilization, export, and lysosomal recycling to keep labile iron within a safe range. Its dysregulation contributes to ferroptosis, cancer, neurodegeneration, and liver disease, making it a high-value area for mechanistic and therapeutic research. CRISPR-based cell models provide powerful tools to establish causal links between specific genes and iron homeostasis phenotypes.

References

  1. 1. Rochette L et al.. 2022. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.. Int J Mol Sci 24(1) PMID: 36613888
  2. 2. Anderson GJ et al.. 2017. Current understanding of iron homeostasis.. Am J Clin Nutr 106(Suppl 6):1559S-1566S PMID: 29070551
  3. 3. Ganz T et al.. 2012. Hepcidin and iron homeostasis.. Biochim Biophys Acta 1823(9):1434-43 PMID: 22306005
  4. 4. Xu L et al.. 2024. Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy.. Adv Sci (Weinh) 11(7):e2306203 PMID: 38063781
  5. 5. Weber RA et al.. 2020. Maintaining Iron Homeostasis Is the Key Role of Lysosomal Acidity for Cell Proliferation.. Mol Cell 77(3):645-655.e7 PMID: 31983508
  6. 6. Xu J et al.. 2022. Iron-responsive riboswitches.. Curr Opin Chem Biol 68:102135 PMID: 35427920
  7. 7. Chen H et al.. 2025. Mechanisms of copper metabolism and cuproptosis: implications for liver diseases.. Front Immunol 16:1633711 PMID: 40808953
  8. 8. Wang L et al.. 2024. Glycine recalibrates iron homeostasis of lens epithelial cells by blocking lysosome-dependent ferritin degradation.. Free Radic Biol Med 210:258-270 PMID: 38042221
Contact Us
*
*
*
*
How did you hear about us: